Coya Therapeutics, Inc.(COYA)

$4.51—Stale · unknown old

Chart

Coya Therapeutics, Inc.(COYA)

NASDAQ • Last print unknown ago

$4.51—Stale · unknown old

Chart Studio

COYA(COYA)

COYA

Overview Fair Value Stream Notebook Intel Chart History Fundamentals TTM Earnings Analysts News Financials Insiders Institl.DCF Peers

Q4 2026 EPS Estimate

$-0.35

Nov 11, 2026 · Reports before open

Revenue Estimate

$110,000

Analyst Sentiment

Wall St. Consensus

Buy

6 analysts·Limited coverage

Score

6 Buy (100%)0 Hold (0%)0 Sell (0%)

Rating Breakdown

Strong Buy

00%

Buy

6100%

Hold

00%

Sell

00%

Strong Sell

00%

Analyst ratings reflect Wall Street opinion, not guarantees. Historical accuracy varies by firm and sector.

Price Target Expectations

Bear

$12.00

+166.1%

Consensus

$12.00

+166.1%

Bull

$12.00

+166.1%

12-Month Target Range6 analysts

$12.00$12.00$12.00

Current $4.51Consensus

Current Price

$4.51

Upside to Consensus

$7.49

Price targets are 12-month analyst forecasts. Actual results depend on earnings, market conditions, and sector trends.

Earnings & Revenue Estimates

Forward Growth Estimates (YoY)

FY2027

Rev+484.16%

EPS—

FY2028

Rev+228.34%

EPS—

FY2029

Rev-94.88%

EPS—

Raw consensus estimates (low / average / high) from covering analysts.

Annual

Metric	FY2026E	FY2027E	FY2028E	FY2029E	FY2030E
Revenue Avg	$1M	$6M	$20M	$1M	$1M
Low	$728,049	$814,698	$999,999	$136,827	$136,827
High	$2M	$12M	$38M	$2M	$2M
EBITDA Avg	$-22M	$-23M	$-19M	$-38M	$-41M
Low	$-23M	$-26M	$-35M	$-90M	$-97M
High	$-21M	$-20M	$-1M	$6M	$6M
EBIT Avg	$-22M	$-23M	$-19M	$-38M	$-41M
Low	$-23M	$-26M	$-35M	$-90M	$-97M
High	$-22M	$-20M	$-1M	$6M	$6M
Net Income Avg	$-22M	$-23M	$-19M	$-38M	$-41M
Low	$-23M	$-26M	$-35M	$-90M	$-97M
High	$-22M	$-20M	$-1M	$5M	$5M
EPS Avg	$-1.33	$-1.43	$-1.07	$-2.28	$-2.46
Low	$-1.37	$-1.58	$-2.08	$-5.37	$-5.80
High	$-1.29	$-1.22	$-0.07	$0.28	$0.30
Analysts (Rev / EPS)	5 / 4	4 / 3	2 / 2	1 / 1	1 / 1

Quarterly

Metric	Q3 2026	Q4 2026	Q1 2027	Q2 2027	Q3 2027	Q4 2027	Q1 2028	Q2 2028
Revenue Avg	$110,000	$660,000	$100,000	$3M	$150,000	$150,000	$310,352	$321,250
Low	$110,000	$660,000	$100,000	$3M	$150,000	$150,000	$310,352	$321,250
High	$110,000	$660,000	$100,000	$3M	$150,000	$150,000	$310,352	$321,250
EBITDA Avg	$-8M	$-9M	$-10M	$-8M	$-7M	$-10M	$-7M	$-7M
Low	$-8M	$-9M	$-10M	$-8M	$-7M	$-10M	$-7M	$-7M
High	$-8M	$-8M	$-10M	$-8M	$-7M	$-10M	$-7M	$-7M
EBIT Avg	$-8M	$-9M	$-10M	$-8M	$-7M	$-10M	$-7M	$-7M
Low	$-8M	$-9M	$-10M	$-8M	$-7M	$-10M	$-7M	$-7M
High	$-8M	$-8M	$-10M	$-8M	$-7M	$-10M	$-7M	$-7M
Net Income Avg	$-8M	$-9M	$-10M	$-8M	$-7M	$-10M	$-7M	$-7M
Low	$-8M	$-9M	$-10M	$-8M	$-7M	$-10M	$-7M	$-7M
High	$-8M	$-8M	$-10M	$-8M	$-7M	$-10M	$-7M	$-7M
EPS Avg	$-0.34	$-0.37	$-0.41	$-0.34	$-0.32	$-0.42	$-0.31	$-0.29
Low	$-0.35	$-0.40	$-0.41	$-0.34	$-0.32	$-0.42	$-0.31	$-0.29
High	$-0.32	$-0.34	$-0.41	$-0.34	$-0.32	$-0.42	$-0.31	$-0.29
Analysts (Rev / EPS)	7 / 3	7 / 2	3 / 1	3 / 1	3 / 1	6 / 1	5 / 1	4 / 1

Earnings Surprises

Recent Analyst Actions

Jun 5, 2026Roth Capital

Coya Therapeutics initiated with a Buy at Roth Capital

Target:$12.00

+146.4%from $4.87

Nov 5, 2025Lake Street

Coya Therapeutics price target raised to $17 from $16 at Lake Street

Target:$17.00

+195.1%from $5.76

Sep 16, 2024H.C. Wainwright

This Yelp Analyst Begins Coverage On A Bearish Note; Here Are Top 5 Initiations For Monday

Target:$18.00

+194.1%from $6.12

Explore More

S&P 500 Screener

Filter and sort all 500 stocks

Market Movers

Today's biggest gainers and losers

Market Heatmap

Visual sector performance